Activating Neuroplasticity to ENHANCE the Perception Box Expanding Effects of Psilocybin
Latest Information Update: 24 Jan 2025
Price :
$35 *
At a glance
- Drugs Psilocybin (Primary)
- Indications Adjustment disorders; Alcoholism; Anxiety disorders; Depressive disorders
- Focus Adverse reactions; Therapeutic Use
- Acronyms ENHANCE
- 24 Jan 2025 New trial record
- 21 Jan 2025 According to a Filament Health media release, the company has shipped drug PEX010 to the University of Wisconsin-Madison (UW-Madison) for investigation in this trial. This trial is United States Food and Drug Administration (FDA)-authorized and expected to begin dosing in Q1 2025. The study is being funded by Tiny Blue Dot Foundation.